KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹844 Cr | ₹743 Cr | ₹650 Cr | ₹611 Cr | ₹439 Cr |
What is the latest Total Liabilities ratio of KOPRAN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹844 Cr |
| Mar2024 | ₹743 Cr |
| Mar2023 | ₹650 Cr |
| Mar2022 | ₹611 Cr |
| Mar2021 | ₹439 Cr |
How is Total Liabilities of KOPRAN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹844 Cr | 13.56 | |
| Mar2024 | ₹743 Cr | 14.40 | |
| Mar2023 | ₹650 Cr | 6.35 | |
| Mar2022 | ₹611 Cr | 39.03 | |
| Mar2021 | ₹439 Cr | - | |
Compare Total Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹595.1 Cr | -5.1% | 0.1% | -31.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -5.1% |
0.1% |
-31.3% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses